Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenue
Product sales, net	$ 10,482,005	$ 9,491,569
Cost of products sold	4,175,533	3,048,260
Gross profit	6,306,472	6,443,309
Selling, general and administrative expenses	11,549,961	9,399,201
Research and development expenses	1,270,471	100,856
Total operating expenses	12,820,432	9,500,057
Loss from operations	(6,513,960)	(3,056,748)
Other (expenses)	(5,088)	(5,347)
Interest income	1,285	3,838
Loss before provision for income tax and equity in net earnings of equity investments	(6,517,763)	(3,058,257)
Provision for income tax	19,101	(36,157)
Loss before equity in net earnings of equity investments	(6,498,662)	(3,094,414)
Income (loss) in equity investments	(795,827)	(2,445,489)
Net Loss	(7,294,489)	(5,539,903)
Net loss attributable to noncontrolling interests	(1,347,982)	(72,381)
Net loss attributable to Milestone Scientific Inc.	$ (5,946,507)	$ (5,467,522)
Net loss per share applicable to common stockholders—
Basic (in dollars per share)	$ (0.22)	$ (0.26)
Diluted (in dollars per share)	$ (0.22)	$ (0.26)
Weighted average shares outstanding and to be issued—
Basic (in shares)	26,966,988	21,429,993
Diluted (in shares)	26,966,988	21,429,993
Milestone Medical Inc. [Member]
Revenue
Income (loss) in equity investments		$ (2,019,211)
Milestone Education LLC [Member]
Revenue
Income (loss) in equity investments		(7,846)
Milestone China [Member]
Revenue
Income (loss) in equity investments	$ (795,827)	$ (418,432)